3,103
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Antitumor activities of carboplatin–doxorubicin–ZnO complexes in different human cancer cell lines (breast, cervix uteri, colon, liver and oral) under UV exposition

, , , , , , & ORCID Icon show all
Pages 120-135 | Received 21 Jul 2020, Accepted 10 Jan 2021, Published online: 25 Jan 2021

References

  • Smith SJ, Pulido JS, Salomão DR, et al. Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds. Br J Ophthalmol. 2012;96(8):1073–1077.
  • Galam N, Tulay P, Adali T. In vitro MCF-7 cells apoptosis analysis of carboplatin loaded silk fibroin particles. Molecules. 2020;25(5):1110.
  • Ouyang J, Yang M, Gong T, et al. Doxorubicin-loading core–shell pectin nanocell: a novel nanovehicle for anticancer agent delivery with multidrug resistance reversal. PLoS One. 2020;15(6):e0535090.
  • Locharoenrat K. Efficacy of nanodiamond–doxorubicin complexes on human breast adenocarcinoma cell lines. Artif Cells Nanomed Biotechnol. 2019;47(1):4053–4058.
  • Xia Y, Tang G, Wang C, et al. Functionalized selenium nanoparticles for targeted siRNA delivery silence Derlin1 and promote antitumor efficacy against cervical cancer. Drug Deliv. 2020;27(1):15–25.
  • Xia Y, Tang G, Guo M, et al. Silencing KLK12 expression via RGDfC-decorated selenium nanoparticles for the treatment of colorectal cancer in vitro and in vivo. Mater Sci Eng C Mater Biol Appl. 2020;110:110594.
  • Xia Y, Zhong J, Zhao M, et al. Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma. Drug Deliv. 2019;26(1):1–11.
  • Xia Y, Xiao M, Zhao M, et al. Doxorubicin-loaded functionalized selenium nanoparticles for enhanced antitumor efficacy in cervical carcinoma therapy. Mater Sci Eng C Mater Biol Appl. 2020;106:110100.
  • Vu M, Kassouf N, Ofili R, et al. Doxorubicin selectively induce apoptosis through the inhibition of a novel isoform of Bcl-2 in acute myeloid leukaemia MOLM-13 cells with reduced Beclin 1 expression. Int J Oncol. 2020;57(1):113–121.
  • Malky HS, Damanhouri ZA, Al-Aama JY, et al. Cytotoxicity and cellular uptake in human breast cancer cells. Breast Cancer Manag. 2019;8(4):BMT31.
  • Christowitz C, Davis T, Isaacs A, et al. Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model. BMC Cancer. 2019;19(1):757.
  • Al-Harthy SE, Al-Motairi MS, Al-Kreathy HM, et al. Enhancement of doxorubicin cytotoxicity by verapamil in human breast cancer cells. J Pharm Res Int. 2019;27(6):1–10.
  • Matcovschii V, Lisii D, Gudumac V, et al. Selective interstitial doxorubicin for recurrent glioblastoma. Clin Case Rep. 2019;7(12):2520–2525.
  • Allen CM, Lopes F, Mitchell RT, et al. Comparative gonadotoxicity of the chemotherapy drugs cisplatin and carboplatin on prepubertal mouse gonads. Mol Hum Reprod. 2020;26(3):129–140.
  • Kuittinen T, Rovio P, Luukkaala T, et al. Paclitaxel, carboplatin and 1,25-D3 inhibit proliferation of ovarian cancer cells in vitro. Anticancer Res. 2020;40(6):3129–3138.
  • Corn PG, Heath EI, Zurita A, et al. Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1–2 trial. Lancet Oncol. 2019;20(10):1432–1433.
  • Lopes F, Liu J, Morgan S, et al. Single and combined effects of cisplatin and doxorubicin on the human and mouse ovary in vitro. Reproduction. 2020;159(2):193–204.
  • Yu DS, Yan HY, Wu CL, et al. Comparison of therapeutic efficacy of lipo-doxorubicin and doxorubicin in treating bladder cancer. Urol Sci. 2017;28(4):200–205.
  • Eroglu O, Kaya H, Celik EG, et al. Triple effect of doxorubicin, 5-fluorouracil, propranolol on cell survival on MCF-7 breast cancer cell line. J Biosci Med. 2019;7(2):74–85.
  • Escobar-Resendiz R, Reyes-Esparza J, Blake IO, et al. Evaluation of antitumoral effect of the combination of l-histidine methyl ester hydrochloride of amphotericin B with antineoplastics on A549 cells. FASEB J. 2020;34(S1):1.
  • Mohammad GRKS, Tabrizi MH, Ardalan T, et al. Green synthesis of zinc oxide nanoparticles and evaluation of anti-angiogenesis, anti-inflammatory and cytotoxicity properties. J Biosci. 2019;44(2):30.
  • Pairoj S, Damrongsak P, Damrongsak B, et al. Antiradical properties of chemo drug, carboplatin, in cooperation with ZnO nanoparticles under UV irradiation in putative model of cancer cells. Biocyber Biomed Eng. 2019;39(3):893–901.
  • Locharoenrat K, Srivatcharakul S. Optical studies of zinc oxide nanoparticles and their biomedical application. Chin J Phys. 2015;53(4):80901.
  • Locharoenrat K. Linear and nonlinear optics: materials, properties, and applications. Singapore: Jenny Stanford; 2020.
  • Asadpour S, Kargozar S, Moradi L, et al. Natural biomacromolecule based composite scaffolds from silk fibroin, gelatin and chitosan toward tissue engineering applications. Int J Biol Macromol. 2020;154:1285–1294.
  • Ganganagappa N, Udayabhanua  , Patil S, et al. Electrochemical heavy metal detection, photocatalytic, photoluminescence, biodiesel production and antibacterial activities of Ag–ZnO nanomaterial. Mater Res Bull. 2017;94:54–63.
  • Nosrati H, Khodaei M, Dehkordi MB, et al. Preparation and characterization of poly(ethylene oxide)/zinc oxide nanofibrous scaffold for chronic wound healing applications. Polim Med. 2020;50(1):41–51.
  • Danmaigoro A, Selvarajah GT, Noor MHM, et al. Development of cockleshell (Anadara granosa) derived CaCO3 nanoparticle for doxorubicin delivery. J Comput Theor Nanosci. 2017;14(10):5074–5086.
  • Iliescu RI, Andronescu E, Ghitulica CD, et al. Montmorillonite–alginate nanocomposite beads as drug carrier for oral administration of carboplatin – preparation and characterization. UPB Sci Bull B. 2011;73(3):3–16.
  • Hoshyar N, Gray S, Han H, et al. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine. 2016;11(6):673–692.
  • Harahap Y, Amalia SN, Anarta A. Analysis of doxorubicin and doxorubicinol in dried blood spot of breast cancer patients for monitoring the cardiotoxicity of doxorubicin. Int J Pharmacy Pharm Sci. 2020;12(4):36707.
  • Alavi AS, Meshkini A. Fabrication of poly(ethylene glycol)-coated mesoporous nanocomposite ZnO@Fe2O3 for methotrexate delivery: an integrated nanoplatform for dual-mode cancer therapy. Eur J Pharm Sci. 2018;115:144–157.
  • Behnamsani A, Meshkini A. Synthesis and engineering of mesoporous ZnO@HAP heterostructure as a pH-sensitive nano-photosensitizer for chemo-photodynamic therapy of malignant tumor cells. J Drug Deliv Sci Technol. 2019;53:101200.
  • Jefri SNS, Abdullah AH, Mohammad EN. Response surface methodology: photodegradation of methyl orange by CuO/ZnO under UV light irradiation. Asian J Green Chem. 2019;3(2):271–287.
  • Mehr ES, Sorbiun M, Ramazani A, et al. Plant-mediated synthesis of zinc oxide and copper oxide nanoparticles by using Ferulago angulata (Schlecht) Boiss extract and comparison of their photocatalytic degradation of rhodamine B (RhB) under visible light irradiation. J Mater Sci Mater Electron. 2018;29(2):1333–1340.
  • Sorbiun M, Mehr ES, Ramazani A, et al. Green synthesis of zinc oxide and copper oxide nanoparticles using aqueous extract of oak fruit hull (Jaft) and comparing their photocatalytic degradation of basic violet 3. Int J Environ Res. 2018;12(1):29–37.
  • Fardood ST, Ramazani A, Moradi A, et al. Green synthesis of zinc oxide nanoparticles using arabic gum and photocatalytic degradation of direct blue 129 dye under visible light. J Mater Sci Mater Electron. 2017;28(18):13596–13601.